Dr. Azimi is Bioniz’ founder, co-inventor of its core technology, and has served as Company’s President and CEO since its inception. Dr. Azimi is a graduate of University of Tehran and recipient of a post-doctoral fellowship program in immunology at one of the premier research groups at the National Institutes of Health (NIH) with a focus on cytokine biology. During her training and later as an independent scientist, she made seminal contributions to the field, and developed the knowledge and the idea that later became the foundation for Bioniz’s multi-cytokine inhibitory platform technology. After NIH, Dr. Azimi joined the faculty at the Fred Hutchinson Cancer Research Center, where she studied immune cytokine responses to herpes virus. Prior to founding Bioniz, Dr. Azimi served as founder and CEO of Dermaheal USA, a privately held dermatology company. Dr. Azimi has authored over 40 peer-reviewed, high impact scientific publications and is the inventor of more than a dozen patents, including the Bioniz intellectual property patent estate. She is an advisor to the Dean of Pharmacy School at the Chapman University. She is also the recipient of 2017 EY Winning Women and 2019 Women in Business in Orange County.